No recent analyst price targets found for NURPF.
Latest News for NURPF
Neuren Pharmaceuticals (OTCMKTS:NURPF) Stock Price Down 13.5% – Should You Sell?
Shares of Neuren Pharmaceuticals Limited (OTCMKTS:NURPF - Get Free Report) were down 13.5% during mid-day trading on Monday. The company traded as low as C$8.53 and last traded at C$8.53. Approximately 2,010 shares were traded during trading, an increase of 104% from the average daily volume of 987 shares. The stock had previously closed
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for NURPF.
Senate Trading
No Senate trades found for NURPF.
U.S. House Trading
No House trades found for NURPF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.